A pre-review of kratom (Mitragyna speciosa), a tree native to Southeast Asia, and its two principal psychoactive alkaloids (mitragynine, 7-hydroxymitragynine), is on the agenda of the 44th WHO Expert Committee on Drug Dependence (ECDD) for their 11-15 October 2021 meeting. Kratom and its compounds have not previously been reviewed by WHO and are not currently under international control, but a number of Southeast Asian and European countries as well as Australia have varying levels of national controls in place. How did kratom get on the ECDD agenda? And what are the chances that this process will ultimately lead to kratom being put under international control?
The UN General Assembly Special Session (UNGASS) on drugs – held in New York in April 2016 – was hailed as an opportunity for the international community ‘to conduct a wide-ranging and open debate that considers all options’. Although the UNGASS was characterised by many shortcomings and disappointments, it was nonetheless a critical moment for global drug policy reform.
The voices of affected communities involved in the cultivation of coca leaf, opium poppy and cannabis plants are lacking in the global debate on drug policy reform in general and were at risk of being excluded from the United Nations General Assembly Special Session (UNGASS) 2016 on The World Drug Problem.
A special session of the General Assembly took place in April revealing a growing divergence in the global drug policy landscape. Difficult negotiations resulted in a disappointing outcome document, perpetuating a siloed approach to drugs at the UN level. There is a clear need to realign international drug policies with the overarching 2030 Agenda and the Sustainable Development Goals, embedding the drugs issue comprehensively within the UN’s three pillars: development, human rights, and peace and security. The UNGASS process has helped to set the stage for more substantial changes in the near future, towards the next UN review in 2019.
Alors que des législatures adoptent des réformes établissant l’accès légal au cannabis pour des fins autres qu’exclusivement « médicales et scientifiques », les tensions entourant les traités actuels des Nations Unies en matière de drogues et l’évolution des lois et pratiques des États membres continuent de s’intensifier. Comment les gouvernements et les systèmes onusiens pourraient-ils aborder ces tensions croissantes par des moyens qui reconnaissent les changements de politiques en cours et qui aident à moderniser le régime des traités sur les drogues, à proprement parler, et par le fait même à renforcer les piliers onusiens des droits humains, du développement, de la paix et de la sécurité ainsi que de la primauté du droit?
The 7th GIZ/TNI Asian Informal Drug Policy Dialogue was organised in collaboration with the National Authority for Combating Drugs (NACD) of the Cambodian Government. Key issues on the agenda were recent trends in the drug market in the region and the development of effective policy responses. Specific attention went to the implementation of the UN Guiding Principles on Alternative Development in the Asian context, including in the implementation of alternative development programmes in conflict areas. The involvement of affected communities in policy making and project implementation was another important theme that was discussed. A major aim of the dialogue was to look at the state of the Asian drug policy before UNGASS 2016.
As jurisdictions enact reforms creating legal access to cannabis for purposes other than exclusively “medical and scientific,” tensions surrounding the existing UN drug treaties and evolving law and practice in Member States continue to grow. How might governments and the UN system address these growing tensions in ways that acknowledge the policy shifts underway and help to modernize the drug treaty regime itself, and thereby reinforce the UN pillars of human rights, development, peace and security, and the rule of law?
The Transnational Institute (TNI) attended the 59th session of the UN Commission on Narcotic Drugs in Vienna from the 14-22nd March. The CND negotiated the outcome document to be approved at the 2016 UNGASS on the world drug problem, to be held on April 19-21 in New York.
This timeline draws on The Rise and Decline of Cannabis Prohibition that described the history of international control, how cannabis was included in the current UN drug control system and the subsequent defections by countries and states that have brought the international treaties to breaking point. As the UN gathers for a special session on drug policy in 2016, TNI is calling for a revision of the treaties to be based on scientific evidence and embodying principles of harm reduction and human rights.
In light of the April 2016 United Nations General Assembly Special Session (UNGASS), a change of the global order on drug policy should be made. Any outcome of UNGASS will have essential developmental impacts on Afghanistan’s economy and especially on those involved in the agricultural production side of the opium economy that is farmers and farm-workers.
Current drug control polices in South-east Asia are repressive and criminalise opium farmers, greatly affecting the lives of communities cultivating opium. Most policy responses – including from some armed opposition groups – focus on eradication of poppy fields and the implementation of strict bans on opium cultivation.
For 37 years Colombia has been spraying chemicals to combat illicit crops, particularly coca. These massive eradication programmes became part of the US-backed 'War on Drugs'. The fumigations are controversial for their proven inefficacy to reduce supply and demand for the use of herbicides such as glyphosate.
Preparations are gathering pace for the United Nations General Assembly Special Session (UNGASS) on drugs, to be held on the 19th to 21st April 2016 in New York. Following several months of discussion on procedural elements, attention is now focused on negotiating the content of the "short, substantive, concise and action-orientated outcome document comprising a set of operational recommendations" to be approved by the General Assembly next April. At the CND intersessional meeting on 12th June, countries and regional groups were invited to submit their first ideas for what could be included in this Outcome Document, by a deadline of 11th September.
Drug policy reform is currently higher on the international agenda than it has been in recent memory. With a United Nations General Assembly Special Session (UNGASS) on drugs set for 19-21 April 2016, the prominence of this issue will further increase. Significant legal and policy reforms at the national level have taken place in recent years that pose considerable challenges to the international legal framework for drug control, and beg important questions regarding states’ international legal obligations.
The international drug control regime is facing the most profound challenge of its existence. Member states have for some time been experimenting with new responses to the ‘world drug problem’; however, the advent of legally regulated cannabis markets has resulted in a ratcheting up of these challenges to expose the system to new levels of strain. With the 2016 UN General Assembly Special Session (UNGASS) on the world drug problem fast approaching, how will the international community make use of the opportunity it provides for a free and open debate?
As the world prepares for the 2016 Special Session of the United Nations General Assembly on the World Drug Problem (UNGASS 2016), an increasing number of countries around the world now find the regime’s emphasis on punitive approaches to illicit drugs to be problematic and are asking for reform. In this moment of global disagreement, the Brookings project on Improving Global Drug Policy provides a unique comparative evaluation of the effectiveness and costs of international counternarcotics policies and best approaches to reform.